To see how the classifier performed by SRR, we performed multivariable analysis including the predicted risk groups from the HTAN DCIS classifier, clinical variables (Age, DCIS grade, RNA-based ER-status, and treatment) and SRR for 5-year follow-up (Fig. 1F). Here, ESR1 is linked to ductal breast carcinoma in situ.